McEwen Stem Cell Institute
101 College St. 8th Floor, room 701 M5G 1L7 Toronto, ON, Canada

On Nov. 30, Dr. Gordon Keller will be speaking at The Globe and Mail’s virtual event, Regenerative Medicine. The webcast will explore the role of stem cells in the future of health care. #RegenMedWebcast To sign up for this free and virtual event, visit: https://tgam.ca/RegenMed

On the 100th anniversary of the discovery of insulin, a team of researchers at University Health NetworkDrs. Maria-Cristina Nostro, Sara Santana Nunes Vasconcelos and Yasaman Aghazadehuncover a new way to increase the survival and functionality of engrafted pancreatic cells. By co-transplanting microvessels with either donor islet cells or stem cell-derived pancreatic progenitor cells into laboratory models, they show that the microvessels are able to connect more effective...ly with the host vasculature, which in turn, improves pancreatic cell survival and glucose response. This finding is closing the gap to using human pluripotent stem cell-derived islets to manage type 1 diabetes. Read more here: https://www.uhn.ca/corporate//Pages/Putting_down_roots.aspx Read the full publication here: https://www.sciencedirect.com//arti/pii/S1934590921003386

The Tenors are helping us take on heart disease with #McEwenCarKaraoke. Join them and help support stem cell research from July 28 to August 29. Register here https://bit.ly/3zZdIsz https://www.youtube.com/watch?v=LSQaRwlICus... UHN Foundation University Health Network Porsche Centre Downtown Toronto #stemcells #celltherapy

Thinking of a road trip this summer? McEwen Stem Cell Institute and Porsche Centre Downtown Toronto are launching #CarKaraoke in support of stem cell research from July 28 to August 29. Register here to sing along and help raise funds https://bit.ly/3zZdIsz

Congratulations to Dr. Michael Laflamme, Senior Scientist and Assistant Director at McEwen Stem Cell Institute, and Cardiac Pathologist at University Health Network, on receiving a new Tier 1 Canada Research Chair in Cardiovascular Regenerative Medicine! Dr. Laflamme's research focuses on restoring heart muscle function after a heart attack by using pluripotent stem cells. #science #research #stemcells #celltherapy... https://www.chairs-chaires.gc.ca/what//crc-2020-1-eng.aspx

McEwen Stem Cell Institute industry partner, BlueRock Therapeutics, administered the first dose of pluripotent stem cell-derived dopamine-producing neurons as part of its Phase 1 clinical trial for Parkinson's disease. Exciting news for BlueRock and an important milestone for the future of cell therapy! https://bluerocktx.com//bluerock-therapeutics-announces-f/

McEwen Stem Cell Institute, Dr. Gordon Keller, is the co-recipient of this year's Institut de France Lefoulon-Delalande Scientific Grand Prize for his research in heart disease. Congratulations to Dr. Gordon Keller, on this incredible achievement!

In this latest Nature Communications publication out of the McEwen Stem Cell Institute, the team led by Dr. Gordon Keller describes a scalable protocol to develop heart muscle from human pluripotent stem cells. The authors characterize the adult-like features of these cells and demonstrate their applications in disease modelling and treatment. Congratulations to Dr. Shunsuke Funakoshi and Ian Fernandes, the lead authors on this paper!... https://www.nature.com/articles/s41467-021-23329-z See more

Exciting progress in advancing cell therapies for the treatment of Parkinson's Disease using stem cell-derived dopaminergic neurons. Congratulations to McEwen Stem Cell Institute industry partner, BlueRock Therapeutics, for obtaining Health Canada approval for Phase 1 #celltherapy Clinical Trial at University Health Network's Krembil Brain Institute. https://bluerocktx.com//bluerock-therapeutics-receives-pe/

Tune in this evening at 5pm to learn about the progress our scientists have made in developing therapies for diabetes. Register here https://bit.ly/3quAjrC

Join us on March 17th at 5pm as Dr. Maria-Cristina Nostro and Dr. Trevor Reichman showcase the innovations in diabetes therapy at University Health Network's McEwen Stem Cell Institute and Ajmera Transplant Centre at UHN. Register here bit.ly/3rFrMTY #TeamUHN

Happy New Year to all from the McEwen Stem Cell Institute family!

The McEwen Stem Cell Institute family wishes everyone a happy, restful and healthy holiday season!

Congratulations to McEwen Stem Cell Institute Senior Scientists, Drs. Gordon Keller and Michael Laflamme, on winning the University Health Network 2020 Local Impact Commercialization - Team Award! This award is in recognition of their pioneering work in #celltherapy research that led to the creation of BlueRock Therapeutics ULC, which is among the largest biotechnology successes in Canada. #lifesciences #biotechnology #stemcells

Tune in this evening at 5pm to learn about the progress our scientists have made in developing therapies for diabetes. Register here https://bit.ly/3quAjrC

Join us on March 17th at 5pm as Dr. Maria-Cristina Nostro and Dr. Trevor Reichman showcase the innovations in diabetes therapy at University Health Network's McEwen Stem Cell Institute and Ajmera Transplant Centre at UHN. Register here bit.ly/3rFrMTY #TeamUHN

Happy New Year to all from the McEwen Stem Cell Institute family!

The McEwen Stem Cell Institute family wishes everyone a happy, restful and healthy holiday season!

Congratulations to McEwen Stem Cell Institute Senior Scientists, Drs. Gordon Keller and Michael Laflamme, on winning the University Health Network 2020 Local Impact Commercialization - Team Award! This award is in recognition of their pioneering work in #celltherapy research that led to the creation of BlueRock Therapeutics ULC, which is among the largest biotechnology successes in Canada. #lifesciences #biotechnology #stemcells

We are immensely proud of McEwen Institute Senior Scientist, Dr. Maria-Cristina Nostro, for being awarded one of two prestigious Canadian Institutes of Health Research-JDRF team grants as part of the initiative to defeat diabetes. She will lead a team of world-renowned #diabetes experts including Drs. Andrew Pepper (University of Alberta), Dan Drucker (Lunenfeld-Tanenbaum Research Institute), Sara Vasconcelos (Toronto General Hospital Research Institute), and Gregory Korbutt ...(University of Alberta) to develop cell therapies for diabetes. Congratulations on this outstanding achievement, Dr. Nostro! https://cihr-irsc.gc.ca/e/52093.html

McEwen Stem Cell Institute Director, Dr. Gordon Keller, is this year’s winner of the Bloom Burton & Co. award for his work as a scientific co-founder of BlueRock Therapeutics. The award honours outstanding contributions made to Canada’s innovative healthcare industry. Congratulations, Dr. Keller, on this well-deserved achievement!

Thank you, Col. Chris Hadfield, for helping us to ignite the revolution and make cell therapies a reality. Watch how our team of scientists is using stem cells to treat cardiac diseases https://bit.ly/36Og9B7 #StemCellResearch #cardiacdisease #TeamUHN

Today's episode of University Health Network's 'Behind the Breakthrough' podcast features McEwen Stem Cell Institute scientist, Dr. Stephanie Protze. Listen to what sparked her interest in regenerative medicine and how she is using stem cells to develop biological pacemakers to regulate the heart beat. Listen here: https://www.podbean.com/ew/pb-wyv88-f0167e

Curious to know how stem cells can be used to treat diseases? Learn about 5 incredible innovations happening at the McEwen Stem Cell Institute

Congratulations to Dr. Stephanie Protze on receiving Stem Cell Network - Réseau de cellules souches funding to support her innovative research focused on developing biological pacemakers using stem cells for patients with sick sinus syndrome!

Meet three of our world-leading researchers, Drs. Gordon Keller, Michael Laflamme and Stephanie Protze, as they take us behind the scenes in this virtual tour moderated by Christian Cote with Toronto General & Western Hospital Foundation. https://www.youtube.com/watch?v=FJJzG9bhXPE&feature=youtu.be

Learn more about the ground-breaking research being done at McEwen Stem Cell Institute to treat diseases of the heart, liver, blood and pancreas.